Brief: Cumberland Pharmaceuticals Says On Oct 28, Co Entered Fourth Amendment To Revolving Credit Note And Fifth Amendment To Revolving Credit Loan Agreement

Cumberland Pharmaceuticals

01/11/2021 22:01

Nov 1 (Reuters) - Cumberland Pharmaceuticals Inc  CPIX.O :
    * CUMBERLAND PHARMACEUTICALS - ON OCT 28, CO ENTERED FOURTH
AMENDMENT TO REVOLVING CREDIT NOTE AND FIFTH AMENDMENT TO
REVOLVING CREDIT LOAN AGREEMENT
    * CUMBERLAND PHARMACEUTICALS INC - ORIGINAL AGREEMENT WITH
PINNACLE BANK WAS DATED JULY 31, 2017
    * CUMBERLAND PHARMACEUTICALS -  FIFTH AMENDMENT PROVIDES FOR
A
PRINCIPAL AVAILABLE FOR BORROWING OF UP TO $15 MILLION
    * CUMBERLAND - HAS RIGHT TO REQUEST AN INCREASE OF UP TO AN
ADDITIONAL $5 MILLION, UPON SATISFACTION OF CERTAIN CONDITIONS,
APPROVAL BY PINNACLE BANK
    * CUMBERLAND PHARMACEUTICALS - IF FULLY EXPANDED, FIFTH
AMENDMENT
WOULD PROVIDE A MAXIMUM PRINCIPAL AVAILABLE FOR BORROWING OF UP
TO $20 MILLION
    * CUMBERLAND PHARMACEUTICALS - FIFTH AMENDMENT EXTENDS
MATURITY
DATE THREE YEARS THROUGH OCT 1, 2024

Source: [ID: https://bit.ly/2ZF0Z15]
Further company coverage:  CPIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))